These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H Eur Respir J; 2015 Feb; 45(2):463-72. PubMed ID: 25323232 [TBL] [Abstract][Full Text] [Related]
3. Systemic corticosteroid use and cardiovascular risk in patients hospitalized for pneumonia. Choi KY; Lee HJ; Lee HW; Park TY; Heo EY; Kim DK; Lee JK Steroids; 2023 Mar; 191():109161. PubMed ID: 36572057 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Moon SM; Kim T; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO Antimicrob Agents Chemother; 2011 Oct; 55(10):4613-8. PubMed ID: 21788460 [TBL] [Abstract][Full Text] [Related]
5. Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia. Cangemi R; Falcone M; Taliani G; Calvieri C; Tiseo G; Romiti GF; Bertazzoni G; Farcomeni A; Violi F; Ann Am Thorac Soc; 2019 Jan; 16(1):91-98. PubMed ID: 30188173 [TBL] [Abstract][Full Text] [Related]
6. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China. Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Siemieniuk RA; Meade MO; Alonso-Coello P; Briel M; Evaniew N; Prasad M; Alexander PE; Fei Y; Vandvik PO; Loeb M; Guyatt GH Ann Intern Med; 2015 Oct; 163(7):519-28. PubMed ID: 26258555 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids for pneumonia. Stern A; Skalsky K; Avni T; Carrara E; Leibovici L; Paul M Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007720. PubMed ID: 29236286 [TBL] [Abstract][Full Text] [Related]
9. Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting. Ambroggio L; Test M; Metlay JP; Graf TR; Blosky MA; Macaluso M; Shah SS J Pediatric Infect Dis Soc; 2015 Mar; 4(1):21-7. PubMed ID: 26407353 [TBL] [Abstract][Full Text] [Related]
10. Analysis of systemic corticosteroid usage and survival in patients requiring mechanical ventilation for severe community-acquired pneumonia. Chon GR; Lim CM; Koh Y; Hong SB J Infect Chemother; 2011 Aug; 17(4):449-55. PubMed ID: 21165755 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis. Wu WF; Fang Q; He GJ Am J Emerg Med; 2018 Feb; 36(2):179-184. PubMed ID: 28756034 [TBL] [Abstract][Full Text] [Related]
12. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Marik PE; Pastores SM; Annane D; Meduri GU; Sprung CL; Arlt W; Keh D; Briegel J; Beishuizen A; Dimopoulou I; Tsagarakis S; Singer M; Chrousos GP; Zaloga G; Bokhari F; Vogeser M; Crit Care Med; 2008 Jun; 36(6):1937-49. PubMed ID: 18496365 [TBL] [Abstract][Full Text] [Related]
13. [Impact of systemic corticosteroids on the clinical outcomes in patients with severe community-acquired pneumonia: a multi-center retrospective study]. Chen L; Han X; Li Y; Zhang C; Xing X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):815-820. PubMed ID: 31441402 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
15. [Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia]. Chen L; Han XD; Li YL; Zhang CX; Xing XQ Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):228-235. PubMed ID: 32234181 [No Abstract] [Full Text] [Related]
16. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Salluh JI; Póvoa P; Soares M; Castro-Faria-Neto HC; Bozza FA; Bozza PT Crit Care; 2008; 12(3):R76. PubMed ID: 18547407 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis. Assal M; Lambert J; Chow-Chine L; Bisbal M; Servan L; Gonzalez F; de Guibert JM; Faucher M; Vey N; Sannini A; Mokart D PLoS One; 2021; 16(4):e0250611. PubMed ID: 33886692 [TBL] [Abstract][Full Text] [Related]
18. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Polverino E; Cillóniz C; Dambrava P; Gabarrús A; Ferrer M; Agustí C; Prina E; Montull B; Menendez R; Niederman MS; Torres A Respirology; 2013 Feb; 18(2):263-71. PubMed ID: 23134361 [TBL] [Abstract][Full Text] [Related]
19. Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Weiss AK; Hall M; Lee GE; Kronman MP; Sheffler-Collins S; Shah SS Pediatrics; 2011 Feb; 127(2):e255-63. PubMed ID: 21220397 [TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Yale SH; Limper AH Mayo Clin Proc; 1996 Jan; 71(1):5-13. PubMed ID: 8538233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]